Clinical Analysis of a Risk-graded and Comprehensive Intervention for Early-childhood-caries

Sponsor
Beijing Friendship Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05260216
Collaborator
(none)
480
1
3
33.9
14.2

Study Details

Study Description

Brief Summary

Cariogram and Cariostat will be used to assess the risk of caries in kindergarten children aged 3 years. Routine preventive measures will be taken for children at low risk of caries, and intensive intervention measures will be taken for children at medium and high risk. Routine measures will be taken for the control group. After one and two year, the prevalence of caries in the experimental group and the control group should be evaluated, and the cost-effectiveness evaluation will be conducted.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Comprehensive prevention and treatment
  • Combination Product: Routine prevention
N/A

Detailed Description

Caries risk-graded intervention for preschool children is needed as different child has different risk to suffer from caries.

Cariogram and Cariostat are two different and common caries risk assessment tools. Cariogram is a complicated but economical computer program which is more sensitive for caries risk assessment. Cariostat is a biological reagents with high specificity but it may be expensive to use for large numbers of children.

The experimental group will be divided into two subgroups, one use Cariogram and the other use Cariostat to assess the risk. Based on the results of the assessment, children with low risk of caries will get routine prevention including twice fluorinated foams each year and hygiene. Children with middle or high risk of caries will receive twice fluorinated varnish each year and professional caries treatment in addition to routine prevention.Routine prevention will be taken for the control group with both Cariogram and Cariostat assessment.

Follow-up will arrange one and two years after baseline recruitment. All participants will receive oral health-related questionnaires at baseline and follow-up.

The prevalence of caries in the experimental group and the control group should be evaluated, and the cost-effectiveness evaluation will be conducted.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
480 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
After the data is entered, the analyst is analyzed under the premise of uninformed, and the packet is performed after all analyzes are completed.
Primary Purpose:
Prevention
Official Title:
Clinical Analysis of Cariogram and Cariostat for Risk Assessment and Comprehensive Intervention of Early-childhood-caries
Actual Study Start Date :
Nov 4, 2021
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
Aug 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental subgroup of Cariostat

Use Cariostat as the caries risk assessment tool to divide the children into different risk levels. Based on the results, children with low risk of caries will receive twice fluoride foam each year and oral hygiene guidance, children with middle or high risk of caries will receive forth fluoride applications each year, oral hygiene guidance and professional caries treatment.

Combination Product: Comprehensive prevention and treatment
Children with low risk of caries will receive routine prevention including fluoride foam application twice a year and oral hygiene guidance. Children with middle or high risk of caries will receive fluoride varnish application twice a year and caries restorative treatment in addition to routine prevention. The risk-graded intervention is one kind of comprehensive prevention and treatment.

Experimental: Experimental subgroup of Cariogram

Use Cariogram as the caries risk assessment tool to divide the children into different risk levels. Based on the results, children with low risk of caries will receive twice fluoride foam each year and oral hygiene guidance, children with middle or high risk of caries will receive forth fluoride applications each year, oral hygiene guidance and professional caries treatment.

Combination Product: Comprehensive prevention and treatment
Children with low risk of caries will receive routine prevention including fluoride foam application twice a year and oral hygiene guidance. Children with middle or high risk of caries will receive fluoride varnish application twice a year and caries restorative treatment in addition to routine prevention. The risk-graded intervention is one kind of comprehensive prevention and treatment.

Placebo Comparator: Control group

Use Cariogram and as the caries risk assessment tool to divide the children into different risk levels. All children will receive routine prevention including wice fluoride foam each year and oral hygiene guidance.

Combination Product: Routine prevention
Routine prevention includes fluoride foam application twice a year and oral hygiene guidance.

Outcome Measures

Primary Outcome Measures

  1. Decay teeth,Missed teeth and filled teeth (DMFT) and the change between different time points. [Baseline, one year follow up and two year follow up.]

    The average value of the sum of the number of decayed teeth, the number of filled teeth, and the number of missed teeth due to caries.

Secondary Outcome Measures

  1. Caries prevalence and the change between different time points. [Baseline, one year follow up and two year follow up.]

    The proportion of population with caries in the whole participants.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 4 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Junior kindergarten children who enter the kindergarten in September 2021 and can cooperate with the oral health examination.

  2. Parents of children fully understand the purpose of the study, cooperate with the questionnaire survey during the study, give informed consent and sign the informed consent form.

  3. The child has no serious systemic diseases, has not taken hormones and immunosuppressants within 6 months, and has no history of antibiotic use within 1 month,and is not allergic to fluoride.

Exclusion Criteria:
  1. Parents of children refuse to provide information about children's oral health or questionnaires.

  2. Children cannot cooperate with oral health examination.

  3. The child has a serious systemic disease that may affect the results of the study.

  4. Children who are allergic to fluoride.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beijing Friendship Hospital, Capital Medical University Beijing Beijing China 10000

Sponsors and Collaborators

  • Beijing Friendship Hospital

Investigators

  • Principal Investigator: Menglin Cheng, Doctor, Beijing Friendship Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beijing Friendship Hospital
ClinicalTrials.gov Identifier:
NCT05260216
Other Study ID Numbers:
  • CARGACIFECC
First Posted:
Mar 2, 2022
Last Update Posted:
Jul 21, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Beijing Friendship Hospital

Study Results

No Results Posted as of Jul 21, 2022